KALMAR INVESTMENTS INC /DE/ - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 194 filers reported holding HAEMONETICS CORP in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
KALMAR INVESTMENTS INC /DE/ ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2013$41,797,000
+5.4%
992,090
-0.3%
0.70%
-0.4%
Q3 2013$39,671,000
+1818.3%
994,750
+1889.5%
0.70%
+1609.8%
Q2 2013$2,068,00050,0000.04%
Other shareholders
HAEMONETICS CORP shareholders Q2 2013
NameSharesValueWeighting ↓
Black Creek Investment Management Inc. 1,014,941$33,077,0003.62%
Camber Capital Management LP 1,202,000$39,173,0003.07%
AMERICAN CAPITAL MANAGEMENT INC 718,380$23,412,0002.76%
Van Berkom & Associates Inc. 1,258,322$41,009,0002.31%
SNYDER CAPITAL MANAGEMENT L P 1,222,547$39,843,0002.07%
KESTREL INVESTMENT MANAGEMENT CORP 441,250$14,380,0001.78%
STONE RUN CAPITAL, LLC 33,740$1,100,0000.80%
HERMES INVESTMENT MANAGEMENT LTD 728,123$23,730,0000.75%
ANCHOR CAPITAL ADVISORS LLC 1,119,060$36,470,0000.73%
Netols Asset Management, Inc. 137,267$4,473,0000.72%
View complete list of HAEMONETICS CORP shareholders